Synbiotics Limited - Due diligence report

A 360° intelligence report on Synbiotics: trust score, financial health, credit view, compliance, directors, growth and distress signals - g…

1960-10-25 Padra, Gujarat Active Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Synbiotics — 360° Intelligence Report

Generated from MCA filings & public records
72/100
Trust Score
Moderate

Synbiotics is assessed as Moderate with a Trust Score of 72/100. Synbiotics is an active public limited indian non-government company incorporated in 1960, operating in the Chemicals sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 11 Nov 2026 from the latest processed filings. Synbiotics Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
72/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
38/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
80/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 80/100 Low Risk
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 6 open (15.65 cr) · 13 satisfied (23.48 cr).

Banking relationships (from registered charges)
LenderChargesAmount
The Kalupur Commercial Co-Operative Bank Limited9 48.0 cr
Others2 48.0 cr
State Bank Of Saurashtra2 48.0 cr
The Kalupur Commercial Co-Operative Bank Ltd.5 48.0 cr
Kalupur Commercial Co-Operative Bank Limited1 48.0 cr
Compliance Score: 38/100 Caution Indicated
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • Flagged by authority: EPFO.
  • Litigation present in 3 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (3)
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
ANURAG MARUTBHAI MEHTA 01234567 Director 01/04/2018 6 yrs Approved
MAYURKUMAR KISHORCHANDRA SWADIA 01234567 Director 01/04/2018 6 yrs Approved
MOHAL KARTIKEYA SARABHAI 01234567 Director 01/04/2018 6 yrs Approved
RAJIV MOHJIT DHRU 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • ANURAG MARUTBHAI MEHTA has DIN status "Deactivated".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2026 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
ASENCE PHARMA PRIVATE LIMITED
Subsidiaries
-
Group entities
1
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
ASENCE PHARMA PRIVATE LIMITED Holding Company 74.00%
COSARA DIAGNOSTICS PRIVATE LIMITED Joint Venture 74.00%

Key managerial personnel: ANURAG MARUTBHAI MEHTA (Whole-time director) · MOHAL KARTIKEYA SARABHAI (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 85 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Profit expanded 2.1x year-on-year.
Net margin improved to 24%.
Operating for 66+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Compliance score is weak (38/100).
6 open charge(s) registered - assets are encumbered.
3 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence64/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment74/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 6 open charge(s) of 15.65 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view85/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
25 Jul 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
22 Dec 2023
Charge satisfied
Others
06 Dec 2023
Charge created
The Kalupur Commercial Co-Operative Bank Limited - 2.00 cr
20 Sep 2023
Director ceased
MOHAL KARTIKEYA SARABHAI
17 Oct 2022
Charge created
The Kalupur Commercial Co-Operative Bank Limited - 1.80 cr
11 Oct 2022
Director appointed
ANURAG MARUTBHAI MEHTA (Whole-time director)
Director ceased
ANURAG MARUTBHAI MEHTA
31 Mar 2022
Charge satisfied
The Kalupur Commercial Co-Operative Bank Limited
Charge satisfied
Others
Charge satisfied
The Kalupur Commercial Co-Operative Bank Ltd.
07 Feb 2022
Director ceased
GULAMMOHIYUDDIN ABDULRAHIM TAMAM
14 Sep 2021
Director ceased
MAYURKUMAR KISHORCHANDRA SWADIA
09 Nov 2020
Director appointed
MAYURKUMAR KISHORCHANDRA SWADIA (Director)
09 Sep 2020
Director ceased
AJOY KUMAR PALIT
10

Key Observations

Auto-generated from the data above
Revenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - manageable leverage.
Net worth is positive.
4 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2026 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Aps Minerals & Additives Private Limited U50402GJ2019PTC110357 Vadodara, Gujarat, India
Lakhani Dyestuffs Private Limited U24114MH1994PTC079809 Mumbai, Maharashtra, India
Blast Carboblocks Private Limited U74999MH1982PTC027100 Navi Mumbai, Maharashtra, India
G.G.Organics Exports Private Limited U24110TN2011PTC083054 Chennai, Tamil Nadu, India
Navketan Pharma Pvt Ltd U24230MH1993PTC071984 Aurangabad, Maharashtra, India
Sri Lakshmi Rosin Private Limited U02411KA1995PTC019062 Malur, Karnataka, India
Sbl Colortech P Ltd U24220MH1993PTC075266 Mumbai, Maharashtra, India
Pharchem Private Limited U24100MH2020PTC337168 Boisar, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Synbiotics before audits and certifications: compliance score 38/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Synbiotics: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 80/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 85/100, margin trends, ownership structure and peer set for Synbiotics - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 72/100, distress signals and MSME payment-delay disclosures - know whether Synbiotics pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Synbiotics - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Synbiotics an active company?

Synbiotics has MCA status “Active” with a compliance score of 38/100 (Caution Indicated).

Is Synbiotics financially healthy?

Synbiotics has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Synbiotics?

Its overall Trust Score is 72/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Synbiotics?

The ultimate holding entity is ASENCE PHARMA PRIVATE LIMITED. 4 active director(s) are on record.

Does Synbiotics have loans or charges against its assets?

6 open charge(s) are registered against its assets, and 13 earlier charge(s) stand satisfied.

Is Synbiotics up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 38/100 (Caution Indicated).

Is it risky to lend to Synbiotics?

Its Credit Risk Score is 80/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.